GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology…
GSK plc and Chimagen Biosciences (Chimagen), a privately held biotechnology company, announced an agreement for GSK…
Trending
- Final Week to Save $350: Accelerate Your Gene Editing Program
- An Interview with Jeffrey Cehelsky, Intellia Therapeutics
- GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline
- Novartis Scemblix FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
- Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
- Iterum Therapeutics Receives FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
- Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis
- Hottest Gene Editing Events Causing Waves in 2024
- AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer’s Disease and Neuroscience Pipeline
- Astellas Provides Update on Marketing Authorization Application for Avacincaptad Pegol (ACP) in the European Union
Top Headlines
Novartis Scemblix FDA approved in newly diagnosed CML, offering superior efficacy, and…
Novartis announced that Scemblix (asciminib) was granted accelerated approval by the US Food and Drug…
Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop…
Biogen Inc. and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders…
Iterum Therapeutics Receives FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment…
Iterum Therapeutics plc announced that the U.S. Food and Drug Administration (FDA) has approved Iterum’s new drug…
Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis
AstraZeneca’s Fasenra (benralizumab) has been approved in the European Union (EU) as an add-on treatment for adult…
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer’s Disease…
AbbVie and Aliada Therapeutics announced a definitive agreement under which AbbVie will acquire Aliada, a…
Clinical Trials
Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
Navidea Biopharmaceuticals, Inc. a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced…
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
Neumora Therapeutics, Inc. announced that the Phase 1 trial of NMRA-266 has been placed on clinical hold by the U.S. Food and Drug Administration…
Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for the…
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to…
Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically…
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic…
PepGen Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the…
Johnson & Johnson reports positive topline results for nipocalimab from a Phase 3 pivotal study…
Johnson & Johnson announced topline results from the pivotal Phase 3 VIVACITY study of nipocalimab in adults living with generalized myasthenia…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Merck Launches First Software for Complete Data Traceability in Microbial QC
Merck, a leading science and technology company, has launched its M-Trace Software & Mobile App, a…
Bayer and Google Cloud to Accelerate Development of AI-powered Healthcare…
Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to…
Drug Research
Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop…
Biogen Inc. and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders…
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License…
AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop…
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific…
AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and…
FDA Grants Orphan Drug Designation to NeoImmuneTech’s NT-I7 for the Treatment of…
NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation…
Bayer and Recursion focus research collaboration on Oncology
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to…
Manufacturing
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing…
Charles River Laboratories International, Inc. and Captain T Cell, a spinoff from the renowned Max Delbrück Center…
Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for…
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization…
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of…
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that…
Astraveus awarded €10.4 million grant by the French government as part of France 2030…
Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT)…
Samsung Biologics and Kurma Partners announce strategic partnership for development and…
Samsung Biologics and Kurma Partners announced a strategic partnership for the development and manufacturing of…
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of…
Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind…
MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO…
Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee,…
Astellas Pharma Inc. announced its intention to submit a planning application to build a new state-of-the-art…
Diseases
SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation…
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to…
Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral…
Kesin Pharma Corporation, a pharmaceutical company focused on innovative Specialty brands and Unit Dose…
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss…
Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc., a clinical-stage biotechnology company dedicated to…
Ionis enters collaboration to advance next generation program targeting Lp(a) for…
Ionis Pharmaceuticals, Inc. announced that it has entered a collaboration and license agreement with Novartis for…
FDA Approves Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of…
Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration…
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First…
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that its partner, Gaelan Medical LLC, a…
